The Opportunity

Join Boehringer Ingelheim at a pivotal moment to shape the future of obesity and metabolic health. This rare launch role will see you shaping the launch and commercialisation of Survodutide, a next‑generation therapy with the potential to redefine patient outcomes. You will lead end‑to‑end brand strategy for a pre‑launch and launch asset, translating insight into action and building a focused market entry strategy in a competitive and rapidly evolving market.

The role offers solid career progression, with the opportunity to step into a future leadership position and build and lead a high‑performing brand team as the franchise grows.

Key Responsibilities

Launch & Brand Strategy

- Lead development and execution of the end‑to‑end launch readiness for Survodutide in Australia

- Build and implement Integrated Customer Plans aligned to pre‑launch and launch milestones

- Develop segmentation, targeting and positioning strategies grounded in deep customer insight





- Define value proposition and messaging across obesity and metabolic health stakeholders

Commercial Planning & Performance

- Develop robust launch scenarios and business cases aligned to launch readiness and ICP

- Monitor brand performance and optimise investment based on ROI and market dynamics

- Lead competitive intelligence to inform strategic decision‑making in a fast‑moving market

Cross‑functional Leadership

- Act as the central connector across Medical, Market Access, Sales, Regulatory, and regional teams

- Lead agency partners to deliver best‑in‑class omnichannel campaigns

- Support field force readiness, including value communication and customer engagement frameworks

Execution Excellence

- Deliver high‑impact omnichannel campaigns, congress strategy, and customer engagement plans

- Ensure all activities meet

📌 Senior Brand Manager - Cardio, Renal, Metabolic - New Product Launch (City of Sydney)
🏢 Boehringer Ingelheim
📍 City of Sydney